Intel Slips After Chipmaker Announces $15 Billion Stock Sale

Intel reported 25.42% revenue growth, with Data Center and AI revenue of $6.26B and Foundry revenue of $5.77B, but still had $2.1B operating losses and a $11.03B GAAP net loss tied to a CHIPS Act escrow charge. Intel shares fell after a $15B stock offering that diluted holders by about one-fifth. Supermicro’s revenue rose 93.16% but shares fell after earnings amid an export-control review.

Intel (INTC) announced a $15 billion all-stock equity offering, reported after market close to be upsized to $20 billion, with banks able to buy an extra $3 billion. The article links this to Intel’s prior CHIPS Act equity conversion and earlier equity sales involving Nvidia (NVDA) and SoftBank (SFTBY). It discusses potential uses including fab buildout and possible buyouts of Brookfield’s stakes.

Intel shares fell about 4% to roughly $97 after the company priced an equity offering. According to the article, Intel sold more than 240 million shares at $95 each, raising about $20 to $23 billion, with the offering later expanded by about a third. Pro forma shares rise to about 5.35 billion and cash increases to about $53 billion, offsetting over $50 billion in debt.

Intel says it will raise about $15 billion through a stock offering to fund factory and equipment spending tied to AI-driven demand. The company reported Q2 2026 revenue of $16.1 billion, up 25% year over year, with Data Center and AI revenue up 59% to $6.3 billion. Banks may add $2.25 billion, and Intel shares fell after the announcement.

Intel priced a $20B equity raise, according to the article, aiming to cut net debt by 95% with about 4% dilution. The piece says Intel’s foundry remains constrained, citing $112M quarterly third-party revenue and $2.1B quarterly losses, and warns CPU pricing may normalize. It discusses INTC valuation and risk.

Intel increased its planned stock offering to $20 billion from $15 billion, priced at $95 per share, with expected net proceeds of about $19.7 billion after underwriting costs, according to CNBC and Reuters. The deal involves about 210.5 million shares, with an option for underwriters to buy up to $2.25 billion more. Proceeds will go to general corporate purposes as AI-driven demand lifts capex and revenue.